Amedisys Total Current Liabilities 2010-2024 | AMED

Amedisys total current liabilities from 2010 to 2024. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
Amedisys Annual Total Current Liabilities
(Millions of US $)
2023 $474
2022 $356
2021 $374
2020 $456
2019 $327
2018 $222
2017 $215
2016 $181
2015 $175
2014 $162
2013 $312
2012 $205
2011 $222
2010 $216
2009 $229
Amedisys Quarterly Total Current Liabilities
(Millions of US $)
2024-09-30 $486
2024-06-30 $480
2024-03-31 $485
2023-12-31 $474
2023-09-30 $468
2023-06-30 $462
2023-03-31 $353
2022-12-31 $356
2022-09-30 $367
2022-06-30 $427
2022-03-31 $380
2021-12-31 $374
2021-09-30 $454
2021-06-30 $449
2021-03-31 $456
2020-12-31 $456
2020-09-30 $437
2020-06-30 $442
2020-03-31 $316
2019-12-31 $327
2019-09-30 $315
2019-06-30 $313
2019-03-31 $297
2018-12-31 $222
2018-09-30 $219
2018-06-30 $214
2018-03-31 $211
2017-12-31 $215
2017-09-30 $202
2017-06-30 $225
2017-03-31 $184
2016-12-31 $181
2016-09-30 $182
2016-06-30 $190
2016-03-31 $200
2015-12-31 $175
2015-09-30 $171
2015-06-30 $176
2015-03-31 $164
2014-12-31 $162
2014-09-30 $191
2014-06-30 $201
2014-03-31 $325
2013-12-31 $312
2013-09-30 $332
2013-06-30 $191
2013-03-31 $203
2012-12-31 $205
2012-09-30 $231
2012-06-30 $245
2012-03-31 $252
2011-12-31 $222
2011-09-30 $210
2011-06-30 $216
2011-03-31 $228
2010-12-31 $216
2010-09-30 $219
2010-06-30 $238
2010-03-31 $239
2009-12-31 $229
2009-09-30 $233
2009-06-30 $217
2009-03-31 $197
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $2.744B $2.236B
Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, orthopedics, complex wound care, geriatric surgical recovery, balance retraining, behavioral health and stroke recovery, as well as various rehabilitative programs. It provides hospice services to patients using an interdisciplinary care team comprising a physician, nurses, home health aides, social workers, therapists, dieticians, volunteers, counselors, chaplains and bereavement coordinators, when required. The company depends on reimbursement from Medicare (for chronic care) for a significant portion of its revenues on account of the age demographics of its patient base (average age of 81).
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.704B 11.92
Quest Diagnostics (DGX) United States $16.912B 17.14
DaVita (DVA) United States $12.098B 15.65
Encompass Health (EHC) United States $9.453B 22.29
Chemed (CHE) United States $7.853B 24.14
Elanco Animal Health (ELAN) United States $5.843B 13.91
RadNet (RDNT) United States $5.284B 117.02
Option Care Health (OPCH) United States $3.848B 18.23
LifeStance Health (LFST) United States $2.698B 0.00
Addus HomeCare (ADUS) United States $2.350B 27.57
Astrana Health (ASTH) United States $1.974B 26.99
U.S Physical Therapy (USPH) United States $1.380B 36.27
Pennant (PNTG) United States $0.938B 37.92
Aveanna Healthcare Holdings (AVAH) United States $0.873B 0.00
Atai Life Sciences (ATAI) Germany $0.200B 0.00
Bioqual (BIOQ) United States $0.059B 0.00
Daxor (DXR) United States $0.039B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00